Generation Bio Co GBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
3.54UNCH (UNCH)
Volume
7,275
Close
3.54quote price arrow up+0.70 (+24.65%)
Volume
372,069
52 week range
0.86 - 6.98
Loading...
  • Open3.77
  • Day High3.77
  • Day Low3.27
  • Prev Close2.84
  • 52 Week High6.98
  • 52 Week High Date07/12/23
  • 52 Week Low0.86
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap235.372M
  • Shares Out66.49M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta2.85
  • YTD % Change114.55

KEY STATS

  • Open3.77
  • Day High3.77
  • Day Low3.27
  • Prev Close2.84
  • 52 Week High6.98
  • 52 Week High Date07/12/23
  • 52 Week Low0.86
  • 52 Week Low Date10/25/23
  • Market Cap235.372M
  • Shares Out66.49M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta2.85
  • YTD % Change114.55

RATIOS/PROFITABILITY

  • EPS (TTM)-2.56
  • P/E (TTM)-1.38
  • Fwd P/E (NTM)-2.39
  • EBITDA (TTM)-133.30M
  • ROE (TTM)-52.14%
  • Revenue (TTM)5.904M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,144.51%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Generation Bio Co

 

Profile

MORE
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that...
Jason Rhodes
Independent Chairman of the Board
Cameron Mcdonough M.D.
President, Chief Executive Officer, Director
Antoinette Paone
Chief Operating Officer
Matthew Norkunas M.D.
Chief Financial Officer
Address
301 BINNEY STREET
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
CLLS
Cellectis SA
3.04+0.07+2.36%
MESO
Mesoblast Ltd
7.20+0.22+3.15%
LCTX
Lineage Cell Therapeutics Inc
1.04-0.05-4.59%
PRQR
ProQR Therapeutics NV
1.99+0.01+0.25%
INMB
INmune Bio Inc
10.49+0.57+5.75%